Transforming high-throughput screening with mass spectrometry
Drug Discovery World
OCTOBER 14, 2022
Reducing assay volumes from about 200 µL to 1 µL ha s cut the quantities of reagents and consumables needed, while automation has replaced manual handling, so lowering running and personnel costs. . One of the other limiting factors for HTS – cost per well analysed – has also been addressed. The future of HTS .
52 
Let's personalize your content